Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines

BACKGROUND: Doxorubicin (DOX) is widely used in both human and veterinary oncology although the onset of multidrug resistance (MDR) in neoplastic cells often leads to chemotherapy failure. Better understanding of the cellular mechanisms that circumvent chemotherapy efficacy is paramount. The aim of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Vet Res
Main Authors: Levi, Michela, Salaroli, Roberta, Parenti, Federico, De Maria, Raffaella, Zannoni, Augusta, Bernardini, Chiara, Gola, Cecilia, Brocco, Antonio, Marangio, Asia, Benazzi, Cinzia, Muscatello, Luisa Vera, Brunetti, Barbara, Forni, Monica, Sarli, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7814552/
https://ncbi.nlm.nih.gov/pubmed/33461558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-020-02709-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados